Starcast
Join the waitlist
Type 2 Diabetes Remission in the GLP-1 Era | Prof Roy Taylor
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
Professor Roy Taylor returns, three years after his first appearance, with the five-year DiRECT trial results and a clear-eyed assessment of where diet-driven type 2 diabetes remission stands in the GLP-1 era. The evidence is now solid: type 2 diabetes is, for many, a reversible condition of excess fat in the liver and pancreas. But keeping it in remission demands keeping the weight off, and the new generation of weight loss drugs comes with marketing claims that Roy says have no evidence behind them. What We Cover: The Twin Cycle Hypothesis and personal fat threshold Five-year DiRECT data: durable remission, halved hospital admissions, fewer cancers Why regaining the weight means the…